Tissue Engineering: Focus on the Cardiovascular System - Biomaterials Science: An Integrated Clinical and Engineering Approach - page 183

32. Gai H, Leung EL, Costantino PD, Aguila JR, Nguyen DM, Fink LM, Ward DC,
Ma Y. Generation and characterization of functional cardiomyocytes using
induced pluripotent stem cells derived from human fibroblasts. Cell Biol Int.
Nov 2009; 33(11): 1184-1193.
33. Tanaka T, Tohyama S, Murata M, Nomura F, Kaneko T, Chen H, Hattori F,
et al. In vitro pharmacologic testing using human induced pluripotent stem
cell-derived cardiomyocytes. Biochem Biophys Res Commun. Aug 7 2009; 385(4):
497-502.
34. Yokoo N, Baba S, Kaichi S, Niwa A, Mima T, Doi H, Yamanaka S, Nakahata
T, Heike T. The effects of cardioactive drugs on cardiomyocytes derived from
human induced pluripotent stem cells. Biochem Biophys Res Commun. Sep 25 2009;
387(3): 482-488.
35. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA,
Kamp TJ. Functional cardiomyocytes derived from human induced pluripotent
stem cells. Circ Res. Feb 27 2009; 104(4): e30-41.
36. Zwi L, Caspi O, Arbel G, Huber I, Gepstein A, Park IH, Gepstein L. Cardiomyocyte
differentiation of human induced pluripotent stem cells. Circulation. Oct 13 2009;
120(15): 1513-1523.
37. Freund C, Mummery CL. Prospects for pluripotent stem cell-derived cardio-
myocytes in cardiac cell therapy and as disease models. J Cell Biochem. Jul 1 2009;
107(4): 592-599.
38. Shiba Y, Hauch KD, Laflamme MA. Cardiac applications for human pluripotent
stem cells. Curr Pharm Des. 2009; 15(24): 2791-2806.
39. Yuasa S, Fukuda K. Recent advances in cardiovascular regenerative medicine:
The induced pluripotent stem cell era. Expert Rev Cardiovasc Ther. Jul 2008; 6(6):
803-810.
40. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J,
Homma S, Edwards NM, Itescu S. Neovascularization of ischemic myocardium
by human bone-marrow-derived angioblasts prevents cardiomyocyte apopto-
sis, reduces remodeling and improves cardiac function. Nat Med. Apr 2001; 7(4):
430-436.
41. Belema Bedada F, Technau A, Ebelt H, Schulze M, Braun T. Activation of myo-
genic differentiation pathways in adult bone marrow-derived stem cells. Mol
Cell Biol. Nov 2005; 25(21): 9509-9519.
42. Flaherty MP, Abdel-Latif A, Li Q, Hunt G, Ranjan S, Ou Q, Tang XL, Johnson
RK, Bolli R, Dawn B. Noncanonical Wnt11 signaling is sufficient to induce car-
diomyogenic differentiation in unfractionated bone marrow mononuclear cells.
Circulation. Apr 29 2008; 117(17): 2241-2252.
43. Koninckx R, Hensen K, Daniels A, Moreels M, Lambrichts I, Jongen H, Clijsters
C, et al. Human bone marrow stem cells co-cultured with neonatal rat cardio-
myocytes display limited cardiomyogenic plasticity. Cytotherapy. 2009; 11(6):
778-792.
44. Koyanagi M, Bushoven P, Iwasaki M, Urbich C, Zeiher AM, Dimmeler S. Notch
signaling contributes to the expression of cardiac markers in human circulating
progenitor cells. Circ Res. Nov 26 2007; 101(11): 1139-1145.
45. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, et al.
Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin
Invest. Mar 1999; 103(5): 697-705.